In the rapidly evolving landscape of psychiatric genetics, a new study is challenging the traditional, gene-centric paradigm of disease research. Published in Human Genetics and Genomics Advances (HGGA), the paper titled "Considering social risk alongside genetic risk for bipolar disorder in the All of Us Research Program" posits that our understanding of mental health is incomplete without a granular analysis of the environment.
The research, led by Dr. Rachel Sharp—a recent graduate of the Neuroscience Curriculum at the University of North Carolina at Chapel Hill—utilizes the massive, diverse dataset provided by the All of Us Research Program. Her findings offer a compelling argument: when it comes to complex psychiatric conditions like bipolar disorder, social and economic stressors may be just as predictive of illness as the genetic variants currently tracked by clinical researchers.
The Genesis of a Holistic Research Approach
Dr. Sharp’s journey toward this research began long before she entered the high-stakes world of statistical genetics. Her motivation is rooted in direct clinical experience. Before pursuing her doctorate, she worked on an emergency room behavioral assessment team and served as a crisis counselor. These front-line roles provided a visceral education in the limitations of reductionist medicine.
"It is impossible to separate a person’s psychological symptoms from their daily life," Dr. Sharp explains. "Most of the time, these illnesses don’t just appear out of nowhere; their onset and severity are deeply entangled with a person’s environment, financial stability, and support systems."
Observing the stark realities of patients in crisis, Sharp noted a disconnect between the clinical environment and the research lab. In the world of statistical genetics, polygenic risk scores (PRS)—the tools used to estimate an individual’s genetic susceptibility to a condition—often fail to capture the full picture. These scores typically explain only a small fraction of bipolar disorder liability, and their predictive accuracy wanes significantly when applied to non-European populations or real-world electronic health record (EHR) biobanks. Driven by these observations, Sharp set out to bridge the chasm between genomic modeling and the lived experience of patients.
Chronology: From Bedside Observations to Data Synthesis
The trajectory of this project was defined by an intentional shift in methodology. Dr. Sharp’s transition from clinical work to the "quantitative world" of statistical genetics required her to reconcile two distinct ways of viewing human health.
Phase I: Redefining Phenotypes
The initial phase of the research involved grappling with the limitations of existing datasets. Unlike model organisms in a laboratory, where environments can be strictly controlled, human lives are inherently "messy." Sharp had to navigate the complexities of EHRs, where diagnostic codes can be influenced by clinician bias, insurance access, or the simple absence of care.
Phase II: Leveraging the All of Us Program
The turning point for the study was the utilization of the All of Us Research Program. Designed specifically to capture longitudinal social and environmental data, the program provided the necessary scale to test whether social determinants could be formally integrated into genetic risk models.
Phase III: The Interdisciplinary Synthesis
By combining the lenses of a geneticist, clinician, epidemiologist, statistician, and bioethicist, Dr. Sharp and her team developed a model that treated social risk as a primary variable. The culmination of this effort was the publication of their findings, which represent a significant departure from the "genes-only" focus of the previous decade.
Supporting Data: The Convergence of Nature and Nurture
The most striking revelation of the study is the comparative weight of social risk versus genetic risk. The data indicates that an individual’s environmental burden can effectively "override" a low genetic predisposition.
According to the study, participants with the lowest genetic risk scores—but who faced a high burden of social risk—exhibited prevalence rates for bipolar disorder that were comparable to, or even exceeded, those observed in individuals with the highest genetic risk but low social burden.
This finding challenges the long-standing belief that genetic risk is the primary determinant of disease onset. It suggests that the "missing heritability" often discussed in genetics literature might not be missing in the DNA at all; rather, it is hidden in the social and environmental factors that trigger or exacerbate psychiatric conditions. These social factors—ranging from financial instability and housing insecurity to limited access to healthcare—are not merely "background noise" in a genetic study; they are active drivers of clinical outcomes.
Official Perspectives and Scientific Implications
Dr. Sharp emphasizes that this research is not intended to minimize the role of genetics, but rather to contextualize it. "We can actually better parse disease liability when we directly account for the lived experiences that differentially shape our health," she states.
Implications for the Genetics Community
The implications for the field are profound. For researchers, this signifies a move away from the "standardized" human model toward a more nuanced, diverse understanding of health. It requires the genetics community to become more comfortable with the messiness of human reality. If researchers continue to study genetics while ignoring the social context, they risk misattributing environmental influences to genetic ones, or vice versa.
Addressing Health Equity
From a policy and clinical perspective, the study highlights critical areas where systemic change can improve outcomes. If high social risk is a major driver of psychiatric prevalence, then clinical resources, community support programs, and public policy interventions are not just "social services"—they are essential components of preventive mental healthcare.
Bridging the Disciplinary Divide
A central theme in Dr. Sharp’s work is the value of the "outside" perspective. As a young scientist coming from a background in psychology and neuroscience, she faced the challenge of translating human experience into quantitative data points.
"When you spend every day looking at diagnostic billing codes and survey scores on a computer screen, you have to be intentional about centering the human experiences that shaped those records," she notes.
Her experience underscores a growing trend in the scientific community: the need for interdisciplinary training. By questioning standard methodologies and remaining grounded in the communities her research serves, Dr. Sharp has turned her non-traditional background into a primary research asset.
The Future of "Risk" Assessment
Looking forward, Dr. Sharp points to recent breakthroughs in other areas of genetics as a guide for the future. She cites a notable study conducted with the Turkana people of Kenya, which revealed that genetic variants associated with cardiometabolic risk in urban environments were actually protective in the traditional, nomadic environments of the participants.
This serves as a cautionary tale for the entire field: genetic variants do not have a fixed, universal effect. Their impact is dictated by the environment in which they exist. As we continue to decode the human genome, the lesson from Dr. Sharp’s research is clear: the environment is not a variable to be ignored or controlled away—it is the very context that gives genetic data its meaning.
By integrating social determinants into the study of bipolar disorder, Dr. Sharp has provided a roadmap for a more human-centric, equitable, and accurate future for genetics. Her work invites the scientific community to look beyond the double helix and see the person, the community, and the environment that shape every human life.
About the Author
